Your browser doesn't support javascript.
loading
Optimized EGFR Blockade Strategies in EGFR Addicted Gastroesophageal Adenocarcinomas.
Corso, Simona; Pietrantonio, Filippo; Apicella, Maria; Migliore, Cristina; Conticelli, Daniela; Petrelli, Annalisa; D'Errico, Laura; Durando, Stefania; Moya-Rull, Daniel; Bellomo, Sara E; Ughetto, Stefano; Degiuli, Maurizio; Reddavid, Rossella; Fumagalli, Uberto; De Pascale, Stefano; Sgroi, Giovanni; Rausa, Emanuele; Baiocchi, Gian Luca; Molfino, Sarah; De Manzoni, Giovanni; Bencivenga, Maria; Siena, Salvatore; Sartore-Bianchi, Andrea; Morano, Federica; Corallo, Salvatore; Prisciandaro, Michele; Di Bartolomeo, Maria; Gloghini, Annunziata; Marsoni, Silvia; Sottile, Antonino; Sapino, Anna; Marchiò, Caterina; Dahle-Smith, Asa; Miedzybrodzka, Zosia; Lee, Jessica; Ali, Siraj M; Ross, Jeffrey S; Alexander, Brian M; Miller, Vincent A; Petty, Russell; Schrock, Alexa B; Giordano, Silvia.
Afiliação
  • Corso S; Department of Oncology, University of Torino, Candiolo, Torino, Italy. silvia.giordano@unito.it simona.corso@unito.it.
  • Pietrantonio F; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Torino, Italy.
  • Apicella M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Migliore C; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Conticelli D; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Torino, Italy.
  • Petrelli A; Department of Oncology, University of Torino, Candiolo, Torino, Italy.
  • D'Errico L; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Torino, Italy.
  • Durando S; Department of Oncology, University of Torino, Candiolo, Torino, Italy.
  • Moya-Rull D; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Torino, Italy.
  • Bellomo SE; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Torino, Italy.
  • Ughetto S; Department of Oncology, University of Torino, Candiolo, Torino, Italy.
  • Degiuli M; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Torino, Italy.
  • Reddavid R; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Torino, Italy.
  • Fumagalli U; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Torino, Italy.
  • De Pascale S; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Torino, Italy.
  • Sgroi G; Department of Oncology, University of Torino, Candiolo, Torino, Italy.
  • Rausa E; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Torino, Italy.
  • Baiocchi GL; Department of Oncology, University of Torino, Orbassano, Torino, Italy.
  • Molfino S; Department of Oncology, University of Torino, Orbassano, Torino, Italy.
  • De Manzoni G; Chirurgia Generale 2, Brescia, Italy.
  • Bencivenga M; Chirurgia Generale 2, Brescia, Italy.
  • Siena S; Surgical Oncology Unit, Department of Surgical Science, ASST Bergamo Ovest, Treviglio, Bergamo, Italy.
  • Sartore-Bianchi A; Surgical Oncology Unit, Department of Surgical Science, ASST Bergamo Ovest, Treviglio, Bergamo, Italy.
  • Morano F; Department of Clinical and Experimental Sciences, Surgical Clinic, University of Brescia, Brescia, Italy.
  • Corallo S; Department of Clinical and Experimental Sciences, Surgical Clinic, University of Brescia, Brescia, Italy.
  • Prisciandaro M; Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, Section of Surgery, University of Verona, Verona, Italy.
  • Di Bartolomeo M; Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, Section of Surgery, University of Verona, Verona, Italy.
  • Gloghini A; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Marsoni S; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Sottile A; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Sapino A; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Marchiò C; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Dahle-Smith A; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Miedzybrodzka Z; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Lee J; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Ali SM; Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Ross JS; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Torino, Italy.
  • Alexander BM; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Torino, Italy.
  • Miller VA; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Torino, Italy.
  • Petty R; Department of Medical Sciences, University of Torino, Torino, Italy.
  • Schrock AB; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Torino, Italy.
  • Giordano S; Department of Medical Sciences, University of Torino, Torino, Italy.
Clin Cancer Res ; 27(11): 3126-3140, 2021 06 01.
Article em En | MEDLINE | ID: mdl-33542076
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Adenocarcinoma / Inibidores de Proteínas Quinases / Anticorpos Monoclonais Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Clin Cancer Res Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Adenocarcinoma / Inibidores de Proteínas Quinases / Anticorpos Monoclonais Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Clin Cancer Res Ano de publicação: 2021 Tipo de documento: Article